{"name": "NeoVista",
 "permalink": "neovista",
 "crunchbase_url": "http://www.crunchbase.com/company/neovista",
 "homepage_url": "http://www.neovistainc.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "news@neovistainc.com",
 "phone_number": "510.933.7600",
 "description": "development of medical technologies",
 "created_at": "Wed Sep 09 14:57:05 UTC 2009",
 "updated_at": "Mon Jan 21 06:31:36 UTC 2013",
 "overview": "\u003Cp\u003ENeoVista, Inc., is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 million people around the world and is a major cause of blindness in men and women over the age of 50.\u003C/p\u003E\n\n\u003Cp\u003EThe unique technology being developed by NeoVista continues to show promise in clinical studies. It is our goal to help improve the quality of care and reduce the burden of this destructive condition on patients, physicians, and the healthcare system.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       102],
      "assets/images/resized/0005/9227/59227v1-max-150x150.jpg"],
     [[219,
       150],
      "assets/images/resized/0005/9227/59227v1-max-250x250.jpg"],
     [[219,
       150],
      "assets/images/resized/0005/9227/59227v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "John",
      "last_name": "N. Hendrick",
      "permalink": "john-n-hendrick",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Marketing \u0026 Sales",
    "person":
     {"first_name": "Tony",
      "last_name": "Moses",
      "permalink": "tony-moses",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Finance",
    "person":
     {"first_name": "Tim",
      "last_name": "Dumke",
      "permalink": "tim-dumke",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$123M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://deals.venturebeat.com/2006/09/18/neovista-a-radiation-treatment-device-maker-to-raise-26m/",
    "source_description": "NeoVista, a radiation treatment device maker, to raise $26M",
    "raised_amount": 26000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 9,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Carlyle Group",
         "permalink": "carlyle-group",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0002/3355/23355v1-max-150x150.png"],
             [[226,
               40],
              "assets/images/resized/0002/3355/23355v1-max-250x250.png"],
             [[226,
               40],
              "assets/images/resized/0002/3355/23355v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Accuitive Medical Ventures",
         "permalink": "accuitive-medical-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/9399/49399v2-max-150x150.png"],
             [[197,
               40],
              "assets/images/resized/0004/9399/49399v2-max-250x250.png"],
             [[197,
               40],
              "assets/images/resized/0004/9399/49399v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://deals.venturebeat.com/2006/12/08/neovista-a-co-targeting-age-related-macular-degeneration-raises-41m/",
    "source_description": "NeoVista, a co. targeting age-related macular degeneration, raises $41M",
    "raised_amount": 41000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 12,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Carlyle Group",
         "permalink": "carlyle-group",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0002/3355/23355v1-max-150x150.png"],
             [[226,
               40],
              "assets/images/resized/0002/3355/23355v1-max-250x250.png"],
             [[226,
               40],
              "assets/images/resized/0002/3355/23355v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Accuitive Medical Ventures",
         "permalink": "accuitive-medical-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/9399/49399v2-max-150x150.png"],
             [[197,
               40],
              "assets/images/resized/0004/9399/49399v2-max-250x250.png"],
             [[197,
               40],
              "assets/images/resized/0004/9399/49399v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "debt_round",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1231108/000123110810000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC D",
    "raised_amount": 3003000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 27,
    "investments":
     []},
   {"round_code": "e",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020110213e72e00001\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "NeoVista Sees $33M From Insiders For Radiation Eye Treatment ",
    "raised_amount": 33000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 13,
    "investments":
     []},
   {"round_code": "debt_round",
    "source_url": "http://www.finsmes.com/2011/03/neovista-receives-20m-debt-financing.html",
    "source_description": "NeoVista Receives $20M Debt Financing",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 3,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Oxford Finance Corporation",
         "permalink": "oxford-finance-corporation",
         "image":
          {"available_sizes":
            [[[114,
               150],
              "assets/images/resized/0006/0701/60701v2-max-150x150.jpg"],
             [[175,
               229],
              "assets/images/resized/0006/0701/60701v2-max-250x250.jpg"],
             [[175,
               229],
              "assets/images/resized/0006/0701/60701v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GE Capital",
         "permalink": "ge-capital",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0002/8620/28620v1-max-150x150.png"],
             [[237,
               62],
              "assets/images/resized/0002/8620/28620v1-max-250x250.png"],
             [[237,
               62],
              "assets/images/resized/0002/8620/28620v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "38875 Cherry Street",
    "address2": "",
    "zip_code": "94560",
    "city": "Newark",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.520587,
    "longitude": -122.011377}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        126],
       "assets/images/resized/0012/6801/126801v1-max-150x150.jpg"],
      [[250,
        210],
       "assets/images/resized/0012/6801/126801v1-max-250x250.jpg"],
      [[450,
        379],
       "assets/images/resized/0012/6801/126801v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}